We also performed a comparative analysis of the CD47 and PD-L1 status of tumor and immune cells in matched peripheral blood and primary and/or metastatic tumor tissue samples to investigate potential variability between the liquid and tumor biopsy. This evidence concerns the gene CD47 and metastatic neoplasm.